Cite
HARVARD Citation
Delforge, M. et al. (n.d.). Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial. Leukemia & lymphoma. 57 (2), pp. 470-473. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Delforge, M. et al. (n.d.). Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial. Leukemia & lymphoma. 57 (2), pp. 470-473. [Online].